DE2240187A1 - Salbe - Google Patents
SalbeInfo
- Publication number
- DE2240187A1 DE2240187A1 DE19722240187 DE2240187A DE2240187A1 DE 2240187 A1 DE2240187 A1 DE 2240187A1 DE 19722240187 DE19722240187 DE 19722240187 DE 2240187 A DE2240187 A DE 2240187A DE 2240187 A1 DE2240187 A1 DE 2240187A1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- pref
- parts
- ointment
- skin disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 14
- 208000017520 skin disease Diseases 0.000 title abstract description 7
- 239000005556 hormone Substances 0.000 title description 2
- 229940088597 hormone Drugs 0.000 title description 2
- 229940088594 vitamin Drugs 0.000 title description 2
- 229930003231 vitamin Natural products 0.000 title description 2
- 235000013343 vitamin Nutrition 0.000 title description 2
- 239000011782 vitamin Substances 0.000 title description 2
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 10
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims abstract description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000186 progesterone Substances 0.000 claims abstract description 5
- 229960003387 progesterone Drugs 0.000 claims abstract description 5
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 5
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 5
- 229940046009 vitamin E Drugs 0.000 claims abstract description 5
- 239000011709 vitamin E Substances 0.000 claims abstract description 5
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 229940041603 vitamin k 3 Drugs 0.000 claims abstract description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 4
- 239000011719 vitamin A Substances 0.000 claims abstract description 4
- 229940045997 vitamin a Drugs 0.000 claims abstract description 4
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 claims abstract description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000011677 pyridoxine Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 3
- 235000008160 pyridoxine Nutrition 0.000 claims description 3
- 229930003270 Vitamin B Natural products 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 3
- 206010039792 Seborrhoea Diseases 0.000 abstract description 3
- 206010000496 acne Diseases 0.000 abstract description 3
- 208000014617 hemorrhoid Diseases 0.000 abstract description 3
- 206010002153 Anal fissure Diseases 0.000 abstract description 2
- 208000016583 Anus disease Diseases 0.000 abstract description 2
- 206010007882 Cellulitis Diseases 0.000 abstract description 2
- 208000034656 Contusions Diseases 0.000 abstract description 2
- 208000001640 Fibromyalgia Diseases 0.000 abstract description 2
- 208000009531 Fissure in Ano Diseases 0.000 abstract description 2
- 208000000112 Myalgia Diseases 0.000 abstract description 2
- 201000004681 Psoriasis Diseases 0.000 abstract description 2
- 208000030533 eye disease Diseases 0.000 abstract description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 abstract 2
- 229960002061 ergocalciferol Drugs 0.000 abstract 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 abstract 2
- 235000001892 vitamin D2 Nutrition 0.000 abstract 2
- 239000011653 vitamin D2 Substances 0.000 abstract 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract 1
- 206010017711 Gangrene Diseases 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 206010040943 Skin Ulcer Diseases 0.000 abstract 1
- 235000019169 all-trans-retinol Nutrition 0.000 abstract 1
- 239000011717 all-trans-retinol Substances 0.000 abstract 1
- -1 belpharitis Diseases 0.000 abstract 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 abstract 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 abstract 1
- WIXFIQKTHUVFDI-UHFFFAOYSA-N menadione sulfonic acid Chemical compound C1=CC=C2C(=O)C(C)(S(O)(=O)=O)CC(=O)C2=C1 WIXFIQKTHUVFDI-UHFFFAOYSA-N 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 abstract 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 abstract 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229960001712 testosterone propionate Drugs 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 239000005426 pharmaceutical component Substances 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010068172 Anal pruritus Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241001608562 Chalazion Species 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000009544 Pruritus Ani Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007510 mood change Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 201000000508 pityriasis versicolor Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
- Salbe Die Erfindung betrifft eine Salbe zur Behandlung und Heilung verschiedener Ha@ Krankheiten, insbesondere von Hautkrankheiten0 Viele Hautkrankheiten werden durch funktionelle Störungen der Talg- und Schweißdrüsen hervorgerufen wie beispielsweise die Acne vulgaris, Seborrhöe u.a.m. Zur Behandlung von Hautkrankheiten dienen Maßnahmen, die den Gesamtorganismus beeinflussen wie Diät, Umstimmung (z.B0 Fieber), Vitamine, Hormone, Antibiotika und chemotherapeutische Mittel und örtliche Maßnahmen wie Umschläge, Puder, Pasten, Salben, Schüttelmixturen, Pinselungen mit Tinkturen, Anwendung verschiedener Strahlenarten (ultraviolett, Röntgen).
- Die erwähnten Behandlungsmethoden zeitigen oft nicht den gewünschten Erfolg oder bringen nur bei ganz bestimmten Hautkrankheiten Erfolge.
- Der Erfindung liegt die Aufgabe zugrunde, eine Heilsalbe vorzuschlagen, die bei einer großen Anzahl von Hautkrankheiten Anwendung finden kann, so daß zahlreiche Krankheiten durch eine einfache Salbenbehandlung heilbar sind.
- Die erfindungsgemäße Salbe ist gekennzeichnet durch Arzneimittelanteile aus Vitamin A -Axerophtolum, Vitamin B 6 - Pyridoxin hydrochloridum, Vitamin C - Acidum ascorbicum, Vitamin D 2 -Calciferolum, Vitamin E - Tocopheroli acetas, Vitamin K 3 - Natrii menadiom bisulfis, Progesteron und Testosteroni propioflas.
- Die beste Heilwirkung wird erzielt mit Arzneimittelanteilen von eta 0,5 Vitamin A -Axerophtolum, 0,25 Vitamin B 6-Pyridoxin hydrochloridum, # 1,00 Vitamin C - Acidum ascorbicum, 0,15 Vitamin D 2-Calciferolum, 0,30 Vitamin E -Tocopheroli acetas, 0,05 Vitamin K 3 - Natrii menadiom bisulfis, 0,05 Progesteron, 0,025 Testosteroni propionas Promilleanteilen.
- Eine Salbe dieser Zusammensetzung ist insbesondere bei folgenden Krankheiten geeignet: Augenkrankheiten : Cunjuctivitis, Blepharitis, Hordeolum und Chalazion.
- Hauckrankheiten : Hautp @ege, Sommersprossen, Atrophien, Altersfalten, Wwidbehandlung, Verbrennung, Sonnenbrand, Acne vulgaris, Psoriasis vulgaris, Rosacae, alle Arten von Ekzemen, Furunkel, Pityriasis versicolor, Kopfschuppen, Seborrhoischer Haarausfall, Seborrhöe, Ulcus cruris und Decubitus.
- Äußere und innere Hämorrhoiden, Fistulae, Pruritus ani, Analfissuren, Phlegmone, Gsanggrene, Prellungen, Myalgien und Muskelrheuma.
- In der Regel genügt bei allen diesen Krankheiten ein zlfeimaliger Salbenauftrag pro Tag innerhalb einer Zeit von vier bis acht Wochen.
- Die beschriebene Heilsalbe verbindet somit die Vorteile der einfachen Salbenbehandlung und einer N mehrfachen Wirksamkeit.
Claims (2)
1. Salbe mit Arzneimittelantoilen aus Vitamin A - Axerophtolum, Vitamin
B 6 - Pyridoxin hydrochloridum, Vitamin C - Acidum ascorbicum, Vitamin D 2 - Calciferolum,
Vitamin E - Tocopheroli acetas, Vitamin K 3 - Natrii menadiom bisulfis, Progesteron,
Testosteroni propionas.
2. Salbe nach Anspruch 1, gekennzeichnet durch etwa 0,45 Vitamin B
A - Axerophtolumt 0,25 Vitamin B 6 - Pyridoxin hydrochloridum, 1,00 Vitamin C -
Acidum ascorbicum, 0,15 Vitamin D 2 -Calciferelum, 0,30 Vitamin E - Tocopheroli
acetas, 0,05 Vitamin K 3 - Natrii menadiom bisulfis, 0,05 Progesteron, 0,025 Testosteroini
Propionas Promilleanteilen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722240187 DE2240187A1 (de) | 1972-08-16 | 1972-08-16 | Salbe |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722240187 DE2240187A1 (de) | 1972-08-16 | 1972-08-16 | Salbe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2240187A1 true DE2240187A1 (de) | 1974-02-21 |
Family
ID=5853678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19722240187 Withdrawn DE2240187A1 (de) | 1972-08-16 | 1972-08-16 | Salbe |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2240187A1 (de) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2385390A1 (fr) * | 1977-04-01 | 1978-10-27 | Marechal Raymond | Compositions topiques a base de composes aromatiques contenant au moins un groupe quinonique ou phenolique, utilisables sur le cuir chevelu |
| EP0001851A1 (de) * | 1977-10-29 | 1979-05-16 | Akzo N.V. | Hochkonzentrierte pharmazeutische Steroidzubereitungen und Verfahren zu ihrer Herstellung |
| FR2477871A1 (fr) * | 1980-03-14 | 1981-09-18 | Gratadour Jean Pierre | Composition destinee a etre utilisee sur le cuir chevelu, notamment pour le traitement des calvities naissantes |
| EP0027987A3 (en) * | 1979-10-22 | 1982-08-04 | Eisai Co., Ltd. | Composition for treating or preventing psoriasis and delta-tocopherol or ester thereof for use in a topical composition |
| WO1983002390A1 (fr) * | 1982-01-20 | 1983-07-21 | Henkel Kgaa | Cosmetiques sebosuppresseurs contenant des alcanols a chaine longue et des antioxygenes |
| EP0129003A3 (en) * | 1983-03-22 | 1985-04-10 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Cosmetic and dermatological compositions containing 1-alpha-hydroxycholecalciferol |
| EP0158090A1 (de) * | 1984-03-07 | 1985-10-16 | Roshdy Dr. Ismail | Mittel zur Behandlung und zum Schutz der Haut |
| EP0129197A3 (en) * | 1983-06-20 | 1986-02-05 | Kao Corporation | Hair growth promoting composition |
| DE3514724A1 (de) * | 1985-04-24 | 1986-10-30 | Albin F. Dr. 4200 Oberhausen Jereb | Salbe zur verbeugung und behandlung von augen- und hauterkrankungen |
| EP0202276A4 (de) * | 1984-11-02 | 1988-09-28 | Gen Hospital Corp | Zubereitung zur behandlung von psoriasis. |
| US4888342A (en) * | 1984-05-16 | 1989-12-19 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
| US5541220A (en) * | 1984-03-07 | 1996-07-30 | Ismail; Roshdy | Agents for the treatment and protection of the skin |
| EP0727985A4 (de) * | 1993-10-22 | 1997-07-02 | Melvin L Elson | Präparat und verfahren zur behandlung von blutgefässerkrankungen der haut unter verwendung von vitamin k |
| WO2001022959A3 (en) * | 1999-09-28 | 2001-10-04 | Univ Pennsylvania | Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| EP1625844A4 (de) * | 2003-05-16 | 2009-05-13 | Lotus Pharmaceutical Co Ltd | Zusammensetzung zur externen anwendung durch perkutane verabreichung |
| EP1889613A4 (de) * | 2005-05-27 | 2010-11-24 | Shionogi & Co | Pharmazeutische zusammensetzung mit vitamin k |
| US8883856B2 (en) * | 2000-02-28 | 2014-11-11 | John Jackson | Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| EP3939561A1 (de) * | 2020-07-15 | 2022-01-19 | Najoi Zbida | Zusammensetzung zur förderung des haarwuchses |
-
1972
- 1972-08-16 DE DE19722240187 patent/DE2240187A1/de not_active Withdrawn
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2385390A1 (fr) * | 1977-04-01 | 1978-10-27 | Marechal Raymond | Compositions topiques a base de composes aromatiques contenant au moins un groupe quinonique ou phenolique, utilisables sur le cuir chevelu |
| DK152721B (da) * | 1977-10-29 | 1988-05-02 | Akzo Nv | Fremgangsmaade til fremstilling af et kraftigt koncentreret, flydende farmaceutisk praeparat af et steroid |
| EP0001851A1 (de) * | 1977-10-29 | 1979-05-16 | Akzo N.V. | Hochkonzentrierte pharmazeutische Steroidzubereitungen und Verfahren zu ihrer Herstellung |
| US4212863A (en) | 1977-10-29 | 1980-07-15 | Akzo N.V. | Highly concentrated pharmaceutical formulations of steroids and processes for their preparation |
| EP0027987A3 (en) * | 1979-10-22 | 1982-08-04 | Eisai Co., Ltd. | Composition for treating or preventing psoriasis and delta-tocopherol or ester thereof for use in a topical composition |
| FR2477871A1 (fr) * | 1980-03-14 | 1981-09-18 | Gratadour Jean Pierre | Composition destinee a etre utilisee sur le cuir chevelu, notamment pour le traitement des calvities naissantes |
| WO1983002390A1 (fr) * | 1982-01-20 | 1983-07-21 | Henkel Kgaa | Cosmetiques sebosuppresseurs contenant des alcanols a chaine longue et des antioxygenes |
| EP0129003A3 (en) * | 1983-03-22 | 1985-04-10 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Cosmetic and dermatological compositions containing 1-alpha-hydroxycholecalciferol |
| EP0129197A3 (en) * | 1983-06-20 | 1986-02-05 | Kao Corporation | Hair growth promoting composition |
| US5786384A (en) * | 1984-03-07 | 1998-07-28 | Ismail; Roshdy | Agents for the treatment and protection of the skin |
| EP0158090A1 (de) * | 1984-03-07 | 1985-10-16 | Roshdy Dr. Ismail | Mittel zur Behandlung und zum Schutz der Haut |
| US5652261A (en) * | 1984-03-07 | 1997-07-29 | Ismail; Roshdy | Method for the treatment and protection of the skin |
| US5541220A (en) * | 1984-03-07 | 1996-07-30 | Ismail; Roshdy | Agents for the treatment and protection of the skin |
| US4888342A (en) * | 1984-05-16 | 1989-12-19 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
| EP0202276A4 (de) * | 1984-11-02 | 1988-09-28 | Gen Hospital Corp | Zubereitung zur behandlung von psoriasis. |
| DE3514724A1 (de) * | 1985-04-24 | 1986-10-30 | Albin F. Dr. 4200 Oberhausen Jereb | Salbe zur verbeugung und behandlung von augen- und hauterkrankungen |
| EP0727985A4 (de) * | 1993-10-22 | 1997-07-02 | Melvin L Elson | Präparat und verfahren zur behandlung von blutgefässerkrankungen der haut unter verwendung von vitamin k |
| WO2001022959A3 (en) * | 1999-09-28 | 2001-10-04 | Univ Pennsylvania | Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| JP2003510277A (ja) * | 1999-09-28 | 2003-03-18 | ユニバーシティー オブ ペンシルバニア | プロゲステロン又はプロゲステロン類縁物質による炎症治療法 |
| US6610674B1 (en) | 1999-09-28 | 2003-08-26 | University Of Pennsylvania | Method of treating inflammatory conditions with progesterone analogs |
| US8883856B2 (en) * | 2000-02-28 | 2014-11-11 | John Jackson | Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| EP1625844A4 (de) * | 2003-05-16 | 2009-05-13 | Lotus Pharmaceutical Co Ltd | Zusammensetzung zur externen anwendung durch perkutane verabreichung |
| EP1889613A4 (de) * | 2005-05-27 | 2010-11-24 | Shionogi & Co | Pharmazeutische zusammensetzung mit vitamin k |
| EP3939561A1 (de) * | 2020-07-15 | 2022-01-19 | Najoi Zbida | Zusammensetzung zur förderung des haarwuchses |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2240187A1 (de) | Salbe | |
| DE3514724C2 (de) | ||
| AT406731B (de) | Stoffgemisch zur topischen anwendung | |
| EP0152106B1 (de) | Rheumamittel | |
| EP0435913B1 (de) | Brausetablette | |
| DE1902227A1 (de) | Arzneimittel zur psychotherapeutischen Anwendung und Verfahren zu seiner Herstellung | |
| EP0209724B1 (de) | Präparat mit Wirkung gegen Akne sowie Verwendung von Wirkstoffextrakt des Queckenweizens | |
| DE69029625T2 (de) | Verwendung von Retinoiden zur Umkehr glucocorticoid-induzierter Hautatrophie | |
| EP1131063B1 (de) | Hyperforin-salbe oder -creme | |
| DE19547317A1 (de) | Antivirales Medikament | |
| DE69927260T2 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| EP0198172B1 (de) | Pharmazeutische Zubereitung | |
| EP0679395A1 (de) | Pharmazeutische Zubereitungen aud der Basis einer Ketoprofenlösung in weichen Gelatinekapseln und Verfahren zu deren Herstellung | |
| DE4028945A1 (de) | Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung | |
| DE3590001T1 (de) | Arzneimittel zur oralen Verabreichung für die Behandlung oder Verhinderung von Akne | |
| EP0366156A1 (de) | Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs | |
| DE2460205A1 (de) | Arzneimittel zur behandlung der dermatomykose | |
| DE69000960T2 (de) | Zusammensetzung zur behandlung von pigmentierung. | |
| KR20130030013A (ko) | 잎새버섯 다당체를 함유하는 피부 외용제 조성물 및 이의 제조방법 | |
| DE102021122184A1 (de) | Normalisierung des Fettstoffwechsels | |
| DE10247339A1 (de) | Psoriasisbehandlung | |
| EP0717994A1 (de) | Neue zusammensetzung zur topischen behandlung der psoriasis | |
| EP3741378A1 (de) | Zusammensetzung zur topischen behandlung und pflege der psoriatischen haut | |
| DE3613717C1 (en) | Composition for the topical treatment of cutaneous diseases | |
| DE1617633A1 (de) | Lotion zur Haarpflege,zur Verhinderung von Haarverlust sowie zur Haar-Regenerierung und -Repigmentierung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |